Zacks Research Has Bearish Forecast for BIO Q2 Earnings
Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Analysts at Zacks Research cut their Q2 2025 EPS estimates for Bio-Rad Laboratories in a research report issued on Monday, June 9th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $2.03 per share for the quarter, down from their previous forecast […]
